Expand ATR Menu
ATR MENU

ATR Latest Press Releases

-- February 18, 2026 --

Aptar to Participate in Upcoming Investor Conferences Business Wire 5:00 PM

-- February 5, 2026 --

Aptar Reports Fourth Quarter and Annual 2025 Results Business Wire 5:00 PM

-- January 22, 2026 --

Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details Business Wire 5:00 PM

-- January 21, 2026 --

Aptar Again Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment Business Wire 5:00 PM

-- January 13, 2026 --

Aptar's Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate Business Wire 5:00 PM

-- January 12, 2026 --

Aptar's Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink Business Wire 5:00 PM

-- January 7, 2026 --

Aptar Announces 2026 Quarterly Conference Call Dates Business Wire 5:00 PM

-- January 6, 2026 --

Aptar Digital Health and OURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy with Oura Ring Business Wire 5:00 PM

-- January 5, 2026 --

Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Business Wire 5:13 PM

-- December 17, 2025 --

Aptar's Bidose Nasal System Delivers CARDAMYST (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) Business Wire 5:00 PM

-- December 4, 2025 --

Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year Business Wire 5:00 PM

-- December 1, 2025 --

Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions Business Wire 5:00 PM

-- November 11, 2025 --

Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025 Business Wire 5:00 PM

-- October 30, 2025 --

Aptar Reports Third Quarter 2025 Results Business Wire 5:00 PM

-- October 16, 2025 --

Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker Sense, a Connected Add-On Device for Metered-Dose Inhalers Business Wire 8:00 AM

-- October 15, 2025 --

Aptar Named Among Top 100 of the 'World's Top Companies for Women 2025' by Forbes Business Wire 5:00 PM
Market Data Delayed 15 Minutes